Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Zhanwang Xiang

Showing results (1-10 of 23) with videos related to

Pageof 3
Sort By:
Journal of Vascular and Interventional Radiology : JVIR|December 29, 2022
Long-term Outcomes of Patients with Hepatocellular Carcinoma Who Underwent Microwave Ablation after Downstaging with Transarterial Chemoembolization to Barcelona Clinic Liver Cancer Stage AHuzheng Yan, Zhanwang Xiang, Chenghao Zhao, et al.
Journal of Vascular and Interventional Radiology : JVIR|August 14, 2024
Clinical Effectiveness of Drug-Eluting Microsphere Transcatheter Arterial Chemoembolization Combined with First-Line Chemotherapy as the Initial Treatment for Patients with Unresectable Intrahepatic CholangiocarcinomaShuyang Luo, Zhanwang Xiang, Mingan Li, et al.
Cancer Imaging : the Official Publication of the International Cancer Imaging Society|February 20, 2022
TIPS improves outcomes in patients with HCC and symptomatic portal hypertension: a multi-institution experienceHuzheng Yan, Zhenkang Qiu, Zhanwang Xiang, et al.
Investigational New Drugs|July 11, 2023
Idarubicin versus epirubicin in drug-eluting beads-transarterial chemoembolization for treating hepatocellular carcinoma: A real-world retrospective studyChenghao Zhao, Huzheng Yan, Zhanwang Xiang, et al.
Journal of Hepatocellular Carcinoma|August 18, 2025
TACE Sequential to Radiofrequency Ablation versus RFA Alone in Hepatocellular Carcinoma Within Milan CriteriaHuzheng Yan, Chenghao Zhao, Mingming Liu, et al.
Journal of Hepatocellular Carcinoma|July 31, 2023
Transarterial Chemoembolization Combined with Atezolizumab Plus Bevacizumab or Lenvatinib for Unresectable Hepatocellular Carcinoma: A Propensity Score Matched StudyChenghao Zhao, Zhanwang Xiang, Mingan Li, et al.
European Radiology|November 25, 2023
6-mm shunt transjugular intrahepatic portosystemic shunt in patients with severe liver atrophy and variceal bleedingHuzheng Yan, Zhanwang Xiang, Chenghao Zhao, et al.
Cancer Management and Research|July 15, 2021
The Clinical Value of Computed Tomography (CT)-Guided <sup>125</sup>I Brachytherapy for Locally Advanced Non-Small Cell Lung Cancer After Progression of Concurrent RadiochemotherapyZhanwang Xiang, Zhihui Zhong, Luwen Mu, et al.
Technology in Cancer Research & Treatment|September 19, 2023
TACE Combined with Lenvatinib and Camrelizumab for Unresectable Multiple Nodular and Large Hepatocellular Carcinoma (>5 cm)Zhanwang Xiang, Guohong Li, Luwen Mu, et al.
Quantitative Imaging in Medicine and Surgery|May 18, 2026
Transfemoral approach TACE technique in orthotopic PDX hepatocellular carcinoma models of nude ratsHuan Liu, Luwen Mu, Chenghao Zhao, et al.
Pageof 3

Showing results (1-10 of 23) with videos related to

Sort By:
Pageof 3
Journal of Vascular and Interventional Radiology : JVIR|December 29, 2022
Long-term Outcomes of Patients with Hepatocellular Carcinoma Who Underwent Microwave Ablation after Downstaging with Transarterial Chemoembolization to Barcelona Clinic Liver Cancer Stage AHuzheng Yan, Zhanwang Xiang, Chenghao Zhao, et al.
Journal of Vascular and Interventional Radiology : JVIR|August 14, 2024
Clinical Effectiveness of Drug-Eluting Microsphere Transcatheter Arterial Chemoembolization Combined with First-Line Chemotherapy as the Initial Treatment for Patients with Unresectable Intrahepatic CholangiocarcinomaShuyang Luo, Zhanwang Xiang, Mingan Li, et al.
Cancer Imaging : the Official Publication of the International Cancer Imaging Society|February 20, 2022
TIPS improves outcomes in patients with HCC and symptomatic portal hypertension: a multi-institution experienceHuzheng Yan, Zhenkang Qiu, Zhanwang Xiang, et al.
Investigational New Drugs|July 11, 2023
Idarubicin versus epirubicin in drug-eluting beads-transarterial chemoembolization for treating hepatocellular carcinoma: A real-world retrospective studyChenghao Zhao, Huzheng Yan, Zhanwang Xiang, et al.
Journal of Hepatocellular Carcinoma|August 18, 2025
TACE Sequential to Radiofrequency Ablation versus RFA Alone in Hepatocellular Carcinoma Within Milan CriteriaHuzheng Yan, Chenghao Zhao, Mingming Liu, et al.
Journal of Hepatocellular Carcinoma|July 31, 2023
Transarterial Chemoembolization Combined with Atezolizumab Plus Bevacizumab or Lenvatinib for Unresectable Hepatocellular Carcinoma: A Propensity Score Matched StudyChenghao Zhao, Zhanwang Xiang, Mingan Li, et al.
European Radiology|November 25, 2023
6-mm shunt transjugular intrahepatic portosystemic shunt in patients with severe liver atrophy and variceal bleedingHuzheng Yan, Zhanwang Xiang, Chenghao Zhao, et al.
Cancer Management and Research|July 15, 2021
The Clinical Value of Computed Tomography (CT)-Guided <sup>125</sup>I Brachytherapy for Locally Advanced Non-Small Cell Lung Cancer After Progression of Concurrent RadiochemotherapyZhanwang Xiang, Zhihui Zhong, Luwen Mu, et al.
Technology in Cancer Research & Treatment|September 19, 2023
TACE Combined with Lenvatinib and Camrelizumab for Unresectable Multiple Nodular and Large Hepatocellular Carcinoma (>5 cm)Zhanwang Xiang, Guohong Li, Luwen Mu, et al.
Quantitative Imaging in Medicine and Surgery|May 18, 2026
Transfemoral approach TACE technique in orthotopic PDX hepatocellular carcinoma models of nude ratsHuan Liu, Luwen Mu, Chenghao Zhao, et al.
Pageof 3